OPTI — Optimi Health Share Price
Last trade - 00:00- CA$16.43m
- CA$19.20m
- CA$0.39m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.9 | ||
| Price to Tang. Book | 1.9 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 33.13 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -45.89% | ||
| Return on Equity | -48.35% | ||
| Operating Margin | -968.59% | ||
Financial Summary
| Year End 30th Sep | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | n/a | 0.08 | 0.18 | 0.39 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Optimi Health Corp. is an end-to-end pharmaceutical drug manufacturer licensed by Health Canada to produce and supply, for clinical research purposes, psychedelic substances, such as 3,4-Methylenedioxymethamphetamine (MDMA), natural Manufacturing Practices (GMP)-grade psilocybin, as well as functional mushrooms that focus on the health and wellness markets. With its vertically integrated approach, the Company owns and operates two purpose built 10,000-square-foot licensed production sites in Princeton, British Columbia and holds a Drug Establishment Licence (DEL), as issued by Health Canada. Additionally, it holds a Dealer’s Licence under Canada’s Narcotic Control Regulations, allowing the Company to possess, produce, assemble, sell and deliver psilocybin and other psychedelic substances within the regulated framework set forth by Health Canada.
Directors
- J Wilson NEC (31)
- William Ciprick CEO (55)
- Jacob Safarik CFO (33)
- Bryan Safarik COO (36)
- Dane Stevens CMO (31)
- Justin Kirkland CSO
- Leah Hodges SEC (38)
- Mike Stier DRC (34)
- Jonathan Schintler IND (43)
- Last Annual
- September 30th, 2024
- Last Interim
- March 31st, 2025
- Incorporated
- May 27th, 2020
- Public Since
- February 25th, 2021
- No. of Employees
- 9
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Canadian Securities Exchange
- Shares in Issue
- 96,638,169
- Address
- Unit 600, 21 Water Street, VANCOUVER, V6B 1A1
- Web
- https://optimihealth.ca/
- Phone
- +1 6043770403
- Auditors
- Smythe LLP
Similar to OPTI
1933 Industries
Canadian Securities Exchange
1CM
Canadian Securities Exchange
Adastra Holdings
Canadian Securities Exchange
Aion Therapeutic
Canadian Securities Exchange
Asia Green Biotechnology
Canadian Securities Exchange
FAQ
As of Today at 22:27 UTC, shares in Optimi Health are trading at CA$0.17. This share price information is delayed by 15 minutes.
Shares in Optimi Health last closed at CA$0.17 and the price had moved by -46.88% over the past 365 days. In terms of relative price strength the Optimi Health share price has underperformed the Toronto Stock Exchange 300 Composite Index by -56.46% over the past year.
There is no consensus recommendation for this security.
Find out moreOptimi Health does not currently pay a dividend.
Optimi Health does not currently pay a dividend.
Optimi Health does not currently pay a dividend.
To buy shares in Optimi Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$0.17, shares in Optimi Health had a market capitalisation of CA$16.43m.
Here are the trading details for Optimi Health:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: OPTI
Based on an overall assessment of its quality, value and momentum Optimi Health is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Optimi Health. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -31.82%.
As of the last closing price of CA$0.17, shares in Optimi Health were trading -17.65% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Optimi Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.17.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Optimi Health's management team is headed by:
- J Wilson - NEC
- William Ciprick - CEO
- Jacob Safarik - CFO
- Bryan Safarik - COO
- Dane Stevens - CMO
- Justin Kirkland - CSO
- Leah Hodges - SEC
- Mike Stier - DRC
- Jonathan Schintler - IND